News
ABVC Biopharma
ABVC · NASDAQ
$0.93+$0.02 (+2.20%)TodayMarket closed ·
Prev close $0.91
Latest news
- News
ABVC BioPharma Postpones Biokey (Cayman) Share Distribution, Rescheduled For August 21, 2026
- NewsAvi Kapoor
Why Silo Pharma Shares Are Trading Higher By Around 52%; Here Are 20 Stocks Moving Premarket
- News
12 Health Care Stocks Moving In Monday's After-Market Session
- News
12 Health Care Stocks Moving In Wednesday's Intraday Session
- News
12 Health Care Stocks Moving In Monday's Intraday Session
- Press releaseGlobe Newswire
ABVC BioPharma Seeks to Revolutionize Mental Health Treatment With a Safe Prozac Alternative, Boasting a MADRS Score Reduction of -13.21
- Press releaseGlobe Newswire
ABVC BioPharma Secures $200,000 in First Cash Licensing Payment From Oncology Products Partner, Totaling $546,000 From Three Partners
- Press releaseGlobe Newswire
ABVC BioPharma, Inc. Reports Q3 2024 Financial Results and Operational Milestones
- News
12 Health Care Stocks Moving In Tuesday's After-Market Session
- Press releaseGlobe Newswire
ABVC BioPharma Receives $50,000 in Incremental Licensing Fees, Boosting Total Payments to $346,000 From Its Three Strategic Partners
- Press releaseGlobe Newswire
ABVC BioPharma, Inc. Reports Strong Q2 2024 Financial Results and Strategic Achievements
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.